352 related articles for article (PubMed ID: 35081304)
1. Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Seo DH; Suh YJ; Cho Y; Ahn SH; Seo S; Hong S; Lee YH; Choi YJ; Lee E; Kim SH
Diabetes Metab J; 2022 Jul; 46(4):630-639. PubMed ID: 35081304
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.
Sun Y; Hong L; Huang Z; Wang L; Xiong Y; Zong S; Zhang R; Liu J; Zang S
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3661-e3669. PubMed ID: 35766414
[TBL] [Abstract][Full Text] [Related]
3. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
[TBL] [Abstract][Full Text] [Related]
4. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus.
Aubert L; Sandino J; Gutiérrez-Solís E; García-Martín F; Segura J; Porrini E; Morales E
Nephrol Dial Transplant; 2022 May; 37(6):1125-1131. PubMed ID: 33983444
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
6. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
Targher G; Mantovani A; Pichiri I; Mingolla L; Cavalieri V; Mantovani W; Pancheri S; Trombetta M; Zoppini G; Chonchol M; Byrne CD; Bonora E
Diabetes Care; 2014 Jun; 37(6):1729-36. PubMed ID: 24696459
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease in nonalcoholic fatty liver disease at primary healthcare centers in Korea.
Nah EH; Shin SK; Cho S; Park H; Kim S; Kwon E; Cho HI
PLoS One; 2022; 17(12):e0279367. PubMed ID: 36538567
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of chronic kidney disease in patients with non-alcoholic fatty liver disease: a Northeastern Taiwan community medicine research cohort.
Huang TS; Wu IW; Lin CL; Shyu YC; Chen YC; Chien RN
Biomed J; 2023 Apr; 46(2):100532. PubMed ID: 35460926
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
Park H; Dawwas GK; Liu X; Nguyen MH
J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
[TBL] [Abstract][Full Text] [Related]
13. The correlation between fatty liver disease and chronic kidney disease.
Chen PC; Kao WY; Cheng YL; Wang YJ; Hou MC; Wu JC; Su CW
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):42-50. PubMed ID: 30876789
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease.
Adrian T; Hornum M; Knop FK; Christensen KB; Almdal T; Rossing P; Lídaa LÍ; Heinrich NS; Boer VO; Marsman A; Petersen ET; Siebner HR; Feldt-Rasmussen B
Nephron; 2023; 147(11):673-684. PubMed ID: 37586348
[TBL] [Abstract][Full Text] [Related]
15. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications.
Lonardo A; Mantovani A; Targher G; Baffy G
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362108
[TBL] [Abstract][Full Text] [Related]
17. Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus.
Mikolasevic I; Domislovic V; Ruzic A; Hauser G; Rahelic D; Klobucar-Majanovic S; Krznaric Z; Dobrila-Dintinjana R; Grgurevic I; Skenderevic N; Lukic A; Targher G
J Diabetes Complications; 2022 Aug; 36(8):108226. PubMed ID: 35803839
[TBL] [Abstract][Full Text] [Related]
18. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
Tanaka M; Mori K; Takahashi S; Higashiura Y; Ohnishi H; Hanawa N; Furuhashi M
Nephrol Dial Transplant; 2023 Feb; 38(3):700-711. PubMed ID: 35612975
[TBL] [Abstract][Full Text] [Related]
19. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
